The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The promise of minocycline in neurology
Abstract
The capacity of minocycline to alleviate disease for several neurological disorders in animals is increasingly being recognised. Indeed, that one drug alone can attenuate the severity of disease in stroke, multiple sclerosis, spinal-cord injury, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis is astounding. In this review, we describe the evidence for the efficacy of minocycline in several animal models of neurological disease, discuss the mechanisms by which minocycline affects a range of neurological diseases with diverse causes, and introduce the emerging investigation of minocycline in clinical neurology. The encouraging results of minocycline in experimental neurology bode well for its therapeutic use in human neurological diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
In the citing paper
“Thanks to the ability to efficiently cross the BBB, minocycline is considered neuroprotective for a variety of neurological conditions, including PD [251,252,253,254,255,256,257].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [253]
Citations
Cites
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Metalloproteinases in biology and pathology of the nervous system
Yong, W. V., Power, C., Forsyth, P., & Edwards, D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,094
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547
Research works printed but not linked: 1
- Giuliani, 2004, Synergistic activity of minocycline and glatiramer acetate in an animal model of multiple sclerosis, Mult Scler, 9, S76
Cited by
Sorted by citations
Items 101–200 of 523
Inflammation in Acute Ischemic Stroke and its Relevance to Stroke Critical Care
Emsley, H. C. A., Smith, C. J., Tyrrell, P. J., & Hopkins, S. J. (2007) · Neurocritical Care · doi:10.1007/s12028-007-9035-x · Cited by 95
Baki, S. G. A., Schwab, B., Haber, M., Fenton, A. A., & Bergold, P. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012490 · Cited by 94
Preventive Antibiotics for Infections in Acute Stroke
van de Beek, D., Wijdicks, E. F. M., Vermeij, F. H., de Haan, R. J., Prins, J. M., Spanjaard, L., Dippel, D. W. J., & Nederkoorn, P. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.176 · Cited by 93
A New Face for Old Antibiotics: Tetracyclines in Treatment of Amyloidoses
Stoilova, T., Colombo, L., Forloni, G., Tagliavini, F., & Salmona, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400161p · Cited by 97
Rojewska, E., Popiołek-Barczyk, K., Jurga, A. M., Makuch, W., Przewłocka, B., & Mika, J. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.020 · Cited by 92
Acute microglia ablation induces neurodegeneration in the somatosensory system
Rubino, S. J., Mayo, L., Wimmer, I., Siedler, V., Brunner, F., Hametner, S., Madi, A., Lanser, A., Moreira, T., Donnelly, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05929-4 · Cited by 91
Zhao, Q., Xie, X., Fan, Y., Zhang, J., Jiang, W. I., Wu, X., Yan, S., Chen, Y., Peng, C. Y., & You, Z. (2015) · Scientific Reports · doi:10.1038/srep09513 · Cited by 92
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases
Dhib-Jalbut, S. S., Arnold, D. L., Cleveland, D. W., Fisher, M., Friedlander, R. M., Mouradian, M. M., Przedborski, S., Trapp, B. D., Wyss‐Coray, T., & Yong, V. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.027 · Cited by 91
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Kielian, T., Esen, N., Liu, S., Phulwani, N. K., Syed, M., Phillips, N., Nishina, K. A., Cheung, A. L., Schwartzman, J. D., & Ruhe, J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070231 · Cited by 88
Vosoughi, R., & Freedman, M. S. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2010.03.010 · Cited by 92
Leal, A. D., Qin, R., Atherton, P. J., Haluska, P., Behrens, R. J., Tiber, C. H., Watanaboonyakhet, P., Weiss, M., Adams, P. T., Dockter, T., et al. (2014) · Cancer · doi:10.1002/cncr.28654 · Cited by 86
Martinez, V., Székély, B., Lemarié, J. C., Martin, F., Gentili, M. E., Ammar, S. B., Lepeintre, J.-F., de Loubresse, C. G., CHAUVIN, M., Bouhassira, D., et al. (2013) · Pain · doi:10.1016/j.pain.2013.03.028 · Cited by 84
Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 91
Réus, G. Z., Manosso, L. M., Quevedo, J., & Carvalho, A. F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105425 · Cited by 94
Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis
Minagar, A., Alexander, J. S., Schwendimann, R. N., Kelley, R. E., Gonzalez‐Toledo, E., Jimenez, J. J., Mauro, L., Jy, W., & Smith, S. J. (2007) · Archives of Neurology · doi:10.1001/archneurol.2007.41 · Cited by 84
Emerging Role of Immunity in Cerebral Small Vessel Disease
Fu, Y., & Yan, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00067 · Cited by 80
Lee, C. Z., Yao, J. S., Huang, Y., Zhai, W., Liu, W., Guglielmo, B. J., Lin, E., Yang, G.-Y., & Young, W. L. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600268 · Cited by 78
Minocycline inhibits the growth of glioma by inducing autophagy
Liu, W., Lin, C.-H., Hsiao, M., & Gean, P. (2011) · Autophagy · doi:10.4161/auto.7.2.14043 · Cited by 78
Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies
Shrestha, P., Katila, N., Lee, S., Seo, J. H., Jeong, J., & Yook, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113591 · Cited by 91
Jiang, Y., Liu, Y., Zhu, C., Ma, X., Ma, L., Zhou, L., Huang, Q., Lei, C., Pi, R., & Chen, X. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.03.003 · Cited by 75
The prospects of minocycline in multiple sclerosis.
Chen, X.-H., Ma, X.-M., Jiang, Y., Pi, R., Liu, Y.-Y., & Ma, L.-L. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.006 · Cited by 75
Weng, Y. C., & Križ, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.003 · Cited by 77
Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice
Hou, Y., Xie, G., Liu, X., Li, G., Jia, C., Xu, J., & Wang, B. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4169-6 · Cited by 76
Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome
Camara-Lemarroy, C. R., Metz, L. M., & Yong, V. W. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i37.4217 · Cited by 77
Fan, X., Lo, E. H., & Wang, X. (2013) · Stroke · doi:10.1161/strokeaha.111.000309 · Cited by 75
Levkovitz, Y., Fenchel, D., Kaplan, Z., Zohar, J., & Cohen, H. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.012 · Cited by 75
Yang, J.-X., Wang, H., Chen, J.-Z., Li, H., Hu, J.-C., Yu, A.-A., Wen, J., Chen, S., Lai, W.-D., Wang, S., et al. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.946846 · Cited by 82
Kim, B. J., Kim, M., Park, J., Lee, S., Kim, Y. J., Ryu, S., Kim, Y. H., & Yoon, B. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.025 · Cited by 73
Pilot Study of Minocycline in Relapsing-Remitting Multiple Sclerosis
Zhang, Y., Metz, L. M., Yong, V. W., Bell, R. B., Yeung, M., Patry, D. G., & Mitchell, J. R. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100008611 · Cited by 72
Improving Outcomes of Neuroprotection by Minocycline
Xue, M., Mikliaeva, E. I., Casha, S., Zygun, D., Demchuk, A. M., & Yong, V. W. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090361 · Cited by 71
Mirshafiey, A., Asghari, B., Ghalamfarsa, G., Jadidi‐Niaragh, F., & Azizi, G. (2014) · Sultan Qaboos University medical journal · doi:10.12816/0003332 · Cited by 73
Zhang, L., Shirayama, Y., Shimizu, E., Iyo, M., & Hashimoto, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.047 · Cited by 71
Franco, E. C. S., Cardoso, M. M., Gouvêia, A., Pereira, A., & Gomes‐Leal, W. (2012) · Neuroscience Research · doi:10.1016/j.neures.2012.03.006 · Cited by 71
Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
Campbell, J. H., Burdo, T. H., Autissier, P., Bombardier, J. P., Westmoreland, S. V., Soulas, C., González, R. G., Ratai, E., & Williams, K. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018688 · Cited by 71
Effective combination of minocycline and interferon-β in a model of multiple sclerosis
Giuliani, F., Fu, S. A., Metz, L. M., & Yong, V. W. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.020 · Cited by 71
Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S. (2018) · Neuroimmunomodulation · doi:10.1159/000492225 · Cited by 70
Angelman syndrome: a journey through the brain
Maranga, C., Fernandes, T. G., Bekman, E., & da Rocha, S. T. (2020) · FEBS Journal · doi:10.1111/febs.15258 · Cited by 78
Attarzadeh-Yazdi, G., Arezoomandan, R., & Haghparast, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.04.008 · Cited by 70
Abrogated Inflammatory Response Promotes Neurogenesis in a Murine Model of Japanese Encephalitis
Das, S., Dutta, K., Kumawat, K. L., Ghoshal, A., Adhya, D., & Basu, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017225 · Cited by 65
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
Hemmer, B., & Hartung, H. (2007) · Annals of Neurology · doi:10.1002/ana.21289 · Cited by 70
Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment
Nakasujja, N., Miyahara, S., Evans, S., Lee, A., Musisi, S., Katabira, E., Robertson, K., Ronald, A., Clifford, D. B., & Sacktor, N. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b9121 · Cited by 67
Inflammatory and structural biomarkers in acute traumatic spinal cord injury
Kwon, B. K., Casha, S., Hurlbert, R. J., & Yong, V. W. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.068 · Cited by 68
Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection
Romero‐Perez, D., Fricovsky, E. S., Yamasaki, K. G., Griffin, M. O., Barraza-Hidalgo, M., DILLMANN, W. H., & Villarreal, F. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.028 · Cited by 69
Martín, A., Boisgard, R., Kassiou, M., Dollé, F., & Tavitian, B. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0324-y · Cited by 68
Lakhan, S. E., & Avramut, M. (2012) · Pain Research and Treatment · doi:10.1155/2012/952906 · Cited by 67
Wang, G., Li, Z., Li, S., Ren, J., Suresh, V., Xu, D., Zang, W., Liu, X., Li, W., Wang, H., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.06.038 · Cited by 67
The Neuroimmunology of Schizophrenia
Annya, M., Smyth, Stephen, M., & Lawrie, S. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.107 · Cited by 68
Disease-Modifying Agents for Multiple Sclerosis
Menge, T., Weber, M. S., Hemmer, B., Kieseier, B. C., von Büdingen, H. ‐., Warnke, C., Zamvil, S. S., Boster, A. L., Khan, O., Hartung, H. P., et al. (2008) · Drugs · doi:10.2165/0003495-200868170-00004 · Cited by 66
Hashimoto, K., Tsukada, H., Nishiyama, S., Fukumoto, D., Kakiuchi, T., & Iyo, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.019 · Cited by 65
Olivera, G. C., Ren, X., Vodnala, S. K., Lu, J., Coppo, L., Leepiyasakulchai, C., Holmgren, A., Kristensson, K., & Rottenberg, M. E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005442 · Cited by 67
Hydrogels as delivery systems for spinal cord injury regeneration
Silva, D., Sousa, R. A., & Salgado, A. J. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100093 · Cited by 66
Promoting repair in multiple sclerosis: problems and prospects
Lubetzki, C., Williams, A., & Stankoff, B. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169739.83793.e0 · Cited by 63
Targeting MMPs in Acute and Chronic Neurological Conditions
Yong, V. W., Agrawal, S. M., & Stirling, D. P. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.005 · Cited by 64
Tetracyclines Modify Translation By Targeting Key Human rRNA Substructures
Mortison, J. D., Schenone, M., Myers, J. A., Zhang, Z., Chen, L., Ciarlo, C., Comer, E., Natchiar, S. K., Carr, S. A., Klaholz, B. P., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.09.010 · Cited by 62
Cai, Z., Zhao, Y., Yao, S., & Zhao, B. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70504-7 · Cited by 62
Reformulating Pro-Oxidant Microglia in Neurodegeneration
García‐Revilla, J., Alonso-Bellido, I. M., Burguillos, M. Á., Herrera, A. J., Espinosa‐Oliva, A. M., Ruiz, R., Cruz-Hernández, L., García-Domínguez, I., Roca-Ceballos, M. A., Santiago, M., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101719 · Cited by 66
Amyotrophic lateral sclerosis: recent advances and future therapies
Nirmalananthan, N., & Greensmith, L. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000187248.21103.c5 · Cited by 60
An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome
Grieco, J. C., Ciarlone, S. L., Gieron-Korthals, M. A., Schoenberg, M. R., Smith, A., Philpot, R. M., Heussler, H., Banko, J. L., & Weeber, E. J. (2014) · BMC Neurology · doi:10.1186/s12883-014-0232-x · Cited by 60
Cai, Z., Yan, & Wang (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s46536 · Cited by 61
Tilakaratne, A., & Soory, M. (2014) · The Open Dentistry Journal · doi:10.2174/1874210601408010109 · Cited by 59
A pilot open-label trial of minocycline in patients with autism and regressive features
Pardo, C. A., Buckley, A., Thurm, A., Lee, L.-C., Azhagiri, A., Neville, D. M., & Swedo, S. E. (2013) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-5-9 · Cited by 58
Remote Neurodegeneration: Multiple Actors for One Play
Viscomi, M. T., & Molinari, M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8629-x · Cited by 59
Clinical and Experimental Advances in Regeneration of Spinal Cord Injury
Hyun, J. K., & Kim, H. (2010) · Journal of Tissue Engineering · doi:10.4061/2010/650857 · Cited by 61
Pachman, D. R., Dockter, T., Zekan, P. J., Fruth, B. F., Ruddy, K. J., Ta, L. E., Lafky, J. M., Dentchev, T., Le-Lindqwister, N. A., Sikov, W. M., et al. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3760-2 · Cited by 58
Adjunct Treatments for Schizophrenia and Bipolar Disorder: What to Try When You Are Out of Ideas
Torrey, E. F., & Davis, J. M. (2011) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.5.4.5 · Cited by 56
Cheng, S., Hou, J., Zhang, C., Xu, C., Wang, L., Zou, X., Yu, H., Shi, Y. S., Yin, Z., & Chen, G. (2015) · Scientific Reports · doi:10.1038/srep10535 · Cited by 59
Minocycline Prevents Osmotic Demyelination Syndrome by Inhibiting the Activation of Microglia
Suzuki, H., Sugimura, Y., Iwama, S., Suzuki, H., Ozaki, N., Nagasaki, H., Arima, H., Sawada, M., & Oiso, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040438 · Cited by 56
Matrix metalloproteinases in intracerebral hemorrhage
Xue, M., & Yong, V. W. (2008) · Neurological Research · doi:10.1179/174313208x341102 · Cited by 58
Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?
Plasilov, M., & Müller, H. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11221 · Cited by 55
Santos, A. G., Santos, D. S., Santos, I. R., Lima, R. R., Pereira, A., de Moura, L. S., de Carvalho, R. N., Lameira, O. A., & Gomes‐Leal, W. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/918174 · Cited by 54
Schmidt, E. K. A., Raposo, P. J. F., Espin, A. T., Fenrich, K. K., & Fouad, K. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02123-0 · Cited by 53
Cuello, A. C., Ferretti, M. T., León, W., Iulita, M. F., Melis, T., Ducatenzeiler, A., Bruno, M. A., & Canneva, F. (2010) · Neurodegenerative Diseases · doi:10.1159/000285514 · Cited by 54
Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
Sloka, S., Metz, L. M., Hader, W., Starreveld, Y., & Yong, V. W. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-89 · Cited by 53
Sönmez, E., Kabataş, S., Özen, Ö., Karabay, G., Türkoğlu, S., Öğüş, E., Yılmaz, C., Caner, H., & Altınörs, N. (2013) · Spine · doi:10.1097/brs.0b013e3182895587 · Cited by 53
Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger, K., Rivera, S., Liechti, F. D., Grandgirard, D., Bigas, J., Seco, J., Tarrago, T., Leib, S. L., & Khrestchatisky, M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00014-1 · Cited by 52
Sheng, Z., Liu, Y., Li, H., Zheng, W., Xia, B., Zhang, X., Yong, V. W., & Xue, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01103 · Cited by 53
de Oliveira, G. B., Fontes-Júnior, E. A., de Carvalho, S., da Silva, J. B., Fernandes, L. M. P., Oliveira, M. C. S. P., Prediger, R. D., Gomes‐Leal, W., Lima, R. R., & Maia, C. D. S. F. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.005 · Cited by 52
Li, J., Ghiani, C. A., Kim, J. Y., Liu, A., Sandoval, J., deVellis, J., & Casaccia‐Bonnefil, P. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0184-08.2008 · Cited by 53
PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease
Hu, W., Metselaar, J. M., Ben, L.-H., Cravens, P. D., Singh, M. P., Frohman, E. M., Eagar, T. N., Racke, M. K., Kieseier, B. C., & Stüve, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004151 · Cited by 50
Tan, A. M., Zhao, P., Waxman, S. G., & Hains, B. C. (2009) · PubMed · Cited by 50
Antibiotic Use and Risk of Multiple Sclerosis
Alonso, Á., Jick, S. S., Jick, H., & Hernán, M. Á. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj123 · Cited by 50
Minocycline treatment reduces white matter damage after excitotoxic striatal injury
Guimarães, J. S., Freire, M. A. M., Lima, R. R., Diniz, C. W. P., Pereira, A., & Gomes‐Leal, W. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.007 · Cited by 49
Amin, B., Hajhashemi, V., Hosseinzadeh, H., & Abnous, K. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.058 · Cited by 48
Minocycline Reduces the Severity of Autonomic Dysreflexia after Experimental Spinal Cord Injury
Squair, J. W., Ruiz, I., Phillips, A. A., Zheng, M. M. Z., Sarafis, Z. K., Sachdeva, R., Gopaul, R., Liu, J., Tetzlaff, W., West, C. R., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5703 · Cited by 52
Kuang, X., Scofield, V. L., Yan, M., Stoica, G., Liu, N., & Wong, P. K. Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.007 · Cited by 47
Treatment trials in progressive MS—current challenges and future directions
Koch, M. W., Cutter, G., Stys, P. K., Yong, V. W., & Metz, L. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.148 · Cited by 46
Immunopathogenesis of Multiple Sclerosis
Agrawal, S. M., & Yong, V. W. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79005-0 · Cited by 46
Gazzin, S., Strazielle, N., Tiribelli, C., & Ghersi‐Egea, J. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00089 · Cited by 45
Alarm or curse? The pain of neuroinflammation
Saab, C. Y., Waxman, S. G., & Hains, B. C. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.04.002 · Cited by 46
Månsson, R., Hansson, M. J., Morota, S., Uchino, H., Ekdahl, C. T., & Elmér, E. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.09.008 · Cited by 46
Liu, Y., Li, Z., Khan, S., Zhang, R., Wei, R., Zhang, Y., Xue, M., & Yong, V. W. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136297 · Cited by 45
Profile of minocycline and its potential in the treatment of schizophrenia
Zhang, L., & Zhao, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s64236 · Cited by 45
Nagoshi, N., & Fehlings, M. G. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1009629 · Cited by 45
Minocycline protects developing brain against ethanol-induced damage
Wang, X., Zhang, K., Yang, F., Ren, Z., Xu, M., Frank, J. A., Ke, Z., & Luo, J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.019 · Cited by 47
Finch‐Edmondson, M., Morgan, C., Hunt, R. W., & Novak, I. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00015 · Cited by 47
Huang, J., Chai, X., Wu, Y., Hou, Y., Li, C., Xue, Y., Pan, J., Zhao, Y., Su, A., Zhu, X., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101469rr · Cited by 46
Karelina, K., Nicholson, S., & Weil, Z. M. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.01.012 · Cited by 44
Therapy with Minocycline Aggravates Experimental Rabies in Mice
Jackson, A. C., Scott, C. A., Owen, J., Weli, S. C., & Rossiter, J. P. (2007) · Journal of Virology · doi:10.1128/jvi.00323-07 · Cited by 44
Lam, T. I., Bingham, D., Chang, T. J., Lee, C. C., Shi, J., Wang, D., Massa, S. M., Swanson, R. A., & Liu, J. (2013) · Neurorehabilitation and neural repair · doi:10.1177/1545968313491003 · Cited by 43
Metadata
- Authors
- Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Yong, V Wee
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 3
- Issue
- 12
- Pages
- 744-751
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2063885093
- Cited by
- 518
- References
- 64
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 17 · 2023: 19 · 2022: 20 · 2021: 19 · 2020: 24 · 2019: 14 · 2018: 27 · 2017: 19 · 2016: 17 · 2015: 28 · 2014: 33 · 2013: 32 · 2012: 35
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Teva Pharmaceutical Industries
- Multiple Sclerosis Society of Canada
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- minocycline, neuroprotection, stroke, multiple sclerosis, spinal cord injury, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, animal models of neurological disease, clinical trials
- MeSH terms
- Animals, Humans, Minocycline, Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review